Holen Sie sich die Stockscreener-App
76.43
0.78%
0.59
Handel nachbörslich:
76.43
Schlusskurs vom Vortag:
$75.84
Offen:
$75.48
24-Stunden-Volumen:
2.37M
Relative Volume:
1.45
Marktkapitalisierung:
$13.24B
Einnahmen:
$8.28B
Nettoeinkommen (Verlust:
$1.43B
KGV:
9.3616
EPS:
8.1642
Netto-Cashflow:
$-203.00M
1W Leistung:
+0.21%
1M Leistung:
+14.71%
6M Leistung:
-10.70%
1J Leistung:
+4.53%
1-Tages-Spanne:
$74.83
$76.71
1-Wochen-Bereich:
$74.15
$77.82
52-Wochen-Spanne:
$62.38
$88.20
Solventum Corp Stock (SOLV) Company Profile
Firmenname
Solventum Corp
Sektor
Telefon
651-733-1110
Adresse
1750 YANKEE DOODLE ROAD, EAGAN
Compare SOLV vs ISRG, BDX, ALC, MDLN, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SOLV
Solventum Corp
|
76.43 | 13.13B | 8.28B | 1.43B | -203.00M | 8.1642 |
ISRG
Intuitive Surgical Inc
|
402.30 | 146.01B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
144.43 | 40.04B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
64.28 | 32.04B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
33.19 | 30.23B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
182.82 | 27.04B | 5.54B | 1.52B | 1.74B | 10.37 |
Solventum Corp Stock (SOLV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-24 | Eingeleitet | Rothschild & Co Redburn | Sell |
| 2026-01-26 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2026-01-20 | Hochstufung | Mizuho | Neutral → Outperform |
| 2025-12-02 | Hochstufung | BTIG Research | Neutral → Buy |
| 2025-10-01 | Eingeleitet | UBS | Neutral |
| 2025-09-11 | Eingeleitet | Jefferies | Hold |
| 2025-07-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2025-07-01 | Hochstufung | Argus | Hold → Buy |
| 2025-06-06 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2025-05-19 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-10-08 | Eingeleitet | Stifel | Buy |
| 2024-10-07 | Eingeleitet | Piper Sandler | Neutral |
| 2024-09-26 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-09-05 | Eingeleitet | BTIG Research | Neutral |
| 2024-06-24 | Eingeleitet | Argus | Hold |
| 2024-05-30 | Eingeleitet | Goldman | Sell |
| 2024-05-10 | Eingeleitet | BofA Securities | Neutral |
| 2024-04-10 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-04-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-04-02 | Eingeleitet | Edward Jones | Hold |
Alle ansehen
Solventum Corp Aktie (SOLV) Neueste Nachrichten
SOLV Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Solventum (SOLV) Q1 2026 Earnings Transcript - AOL.com
Solventum Corp. stock rises Monday, outperforms market - MarketWatch
Solventum Corporation (SOLV) Stock Analysis: Strong Return on Equity and Investor Ratings Signal Potential Growth - DirectorsTalk Interviews
3M Company stock (US88579Y1010): technical picture in focus after Solventum spin-off and PFAS headli - AD HOC NEWS
3M Company stock (US88579Y1010): shares react to recent spin-off of Solventum and technical picture - AD HOC NEWS
Executives at Solventum commute to Minnesota by plane. A shareholder wants to change that - MSN
Solventum (SOLV) recently broke out above the 200-day moving average - MSN
Solventum Corp. stock falls Friday, underperforms market - MarketWatch
Trian Presses Solventum Over Private‑Jet Exec Commutes - Hoodline
Minnesota’s Solventum to pay $1.6M fine for selling equipment to Chinese firms - MSN
Executives at this Minnesota company commute here by plane. A shareholder wants to change that. - Star Tribune
Solventum (SOLV) Q4 2025 Earnings Call Transcript - Fortune
Top Solventum (SOLV) Competitors 2026 - MarketBeat
Solventum Adopts Updated Executive Severance and Compensation Plan - The Globe and Mail
Solventum Corporation 8-K Filing: Executive Severance Plan, Key Company Information & NYSE Listing (2026) - Minichart
3M Company stock (US88579Y1010): Spin-off of Solventum reshapes the conglomerate - AD HOC NEWS
Solventum to Participate in the 2026 Jefferies Healthcare Conference - Nasdaq
Goldman Sachs Adjusts Price Target on Solventum to $67 From $66, Maintains Sell Rating - marketscreener.com
3M Company stock (US88579Y1010): Spin-off of Solventum reshapes the industrial giant - AD HOC NEWS
Analysts Offer Insights on Healthcare Companies: Bristol-Myers Squibb (BMY), BillionToOne, Inc. Class A (BLLN) and Solventum Corporation (SOLV) - The Globe and Mail
Solventum Beats Consensus Estimates for 1Q26 - Medical Device and Diagnostic industry
Solventum Corporation (SOLV) Stock Report: Is A 6.83% Upside Worth The Dive? - DirectorsTalk Interviews
3M Company stock (US88579Y1010): spin-off, earnings pressure and legal risks in focus - AD HOC NEWS
Assessing Solventum (SOLV) Valuation As Recent Momentum Meets Perceived Undervaluation - simplywall.st
Solventum stock is recovering: What's going on? - MSN
3M Company stock (US88579Y1010): Q1 2026 earnings and Solventum spin-off reshape the industrial gian - AD HOC NEWS
Solventum Corp. stock rises Wednesday, outperforms market - MarketWatch
Solventum Shareholders Back Board, Pay and Auditor Choices - TipRanks
Solventum (NYSE: SOLV) shareholders approve directors, pay plan and PwC auditor - Stock Titan
Solventum Corp. stock falls Tuesday, underperforms market - MarketWatch
Will Activist Pressure and Reaffirmed EPS Guidance Reshape Solventum's (SOLV) Transformation Narrative? - simplywall.st
What Are Wall Street Analysts' Target Price for Solventum Stock? - Barchart.com
Solventum gains after activist Trian sends letter urging changes (update) - MSN
Solventum (SOLV) director Carlos Alban receives 3,300 restricted stock units - Stock Titan
Solventum Corp (SOLV) director receives 4,848 restricted stock units - Stock Titan
Solventum (SOLV) director Susan DeVore awarded 3,300 restricted stock units - Stock Titan
Solventum (SOLV) director receives 3,300 Restricted Stock Units as equity grant - Stock Titan
Director Glenn Eisenberg receives 3,300 Solventum (SOLV) restricted stock units - Stock Titan
Solventum (SOLV) director awarded 3,300 RSUs vesting in 2027 - Stock Titan
Solventum (SOLV) director Karen May receives grant of 3,300 RSUs - Stock Titan
Director at Solventum (NYSE: SOLV) receives 3,300 RSU equity grant - Stock Titan
Solventum Corp (SOLV) director receives grant of 3,300 RSUs vesting 2027 - Stock Titan
Solventum (SOLV) director awarded 3,300 restricted stock units vesting in 2027 - Stock Titan
Solventum (SOLV) director receives 3,300 RSU award vesting in 2027 - Stock Titan
Solventum (SOLV) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - MSN
Solventum Corporation (SOLV) Stock Analysis: Exploring a 10.53% Upside in the Healthcare Sector - DirectorsTalk Interviews
3M Company stock (US88579Y1010): spin-off of Solventum reshapes the Dow veteran - AD HOC NEWS
Wedbush initiates coverage of Solventum (SOLV) with outperform recommendation - MSN
Solventum (NYSE: SOLV) CHRO settles RSUs with tax withholding, updates share stake - Stock Titan
Solventum (SOLV) CFO exercises RSUs and uses 4,404 shares for taxes - Stock Titan
Finanzdaten der Solventum Corp-Aktie (SOLV)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.81%
1.52%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):